- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of herpes zoster virus
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (DOCX)
Recombinant Zoster Vaccine – November 2025
Powder and suspension for injection (0.5mL)
Last updated
5 November 2025